Publications by authors named "Daniel Gil Alos"

Claim this Profile
G
GMP-compliant manufacturing of allogeneic peripheral blood CAR-NK cells for the treatment of acute myeloid leukemia.
Laura Córdoba-Espejo, Laura Sánchez-Vega, Almudena García-Ortiz, Eva Castellano, Raquel Oliva

Cytotherapy· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR T cells.
Corynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar, Amrik S Kang, Nikhil Chilakapati

Blood· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell Malignancies.
Adila Izgutdina, Tasfia Rashid, William C Temple, Bonell Patiño-Escobar, Sujata Walunj

bioRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells.
Corynn Kasap, Adila Izgutdina, Bonell Patiño-Escobar, Amrik Kang, Nikhil Chilakapati

bioRxiv· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients.
Ana Jiménez-Ubieto, Alejandro Martín-Muñoz, María Poza, Sara Dorado, Almudena García-Ortiz

Front Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased von Willebrand factor antigen and low ADAMTS13 activity are related to poor prognosis in covid-19 patients.
Mario Rodríguez Rodríguez, Nerea Castro Quismondo, Denis Zafra Torres, Daniel Gil Alos, Rosa Ayala

Int J Lab Hematol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies.
José María Sanchez-Pina, Mario Rodríguez Rodriguez, Nerea Castro Quismondo, Rodrigo Gil Manso, Rafael Colmenares, Daniel Gil Alos

Eur J Haematol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis